# Nuclide record fluoroestradiol-f18 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/fluoroestradiol-f18/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "fluoroestradiol-f18" ;
  schema:name "Fluoroestradiol F-18 (FES PET)"@en ;
  schema:description "A PET scan that shows which breast cancer deposits still have oestrogen receptors, helping decide whether hormone therapy will work when biopsy is impractical."@en ;
  schema:url <https://nuclide.cc/drugs/fluoroestradiol-f18/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fluoroestradiol_F-18> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Cerianna> ;
  nuclide:status "approved" ;
  nuclide:tag "gap-fill", "diagnostic" ;
  nuclide:modality "PET radiotracer (oestrogen receptor ligand)" ;
  schema:alternateName "Cerianna" ;
  nuclide:approval "US 2020: Detection of ER-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:companies <https://nuclide.cc/companies/ge-healthcare/> .